Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Viral Vector Manufacturing Market Report 2024

Viral Vector Manufacturing Global Market Report 2025 – By Type (Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Other Diseases), By Workflow (Upstream Processing, Downstream Processing), By Application (Gene And Cell Therapy Development, Vaccine Development, Biopharmaceutical And Pharmaceutical Discovery, Biomedical Research), By End-User (Research Organizations, Biotech And Pharmaceutical Companies, Others End Users) – Market Size, Trends, And Global Forecast 2025-2034

Viral Vector Manufacturing Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Viral Vector Manufacturing Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Viral Vector Manufacturing Market Definition

Viral vector manufacturing refers to producing viral vectors, tools that deliver genetic material into cells. A viral vector is a tool for gene transfer that can manipulate a particular cell type or tissue to express therapeutic genes.

The main types of viral vector manufacturing are adenoviral vectors, adeno-associated viral vectors, Lentiviral Vectors, retroviral vectors, and others. Adenoviral vectors refer to double-stranded DNA vectors that are not enclosed. The various diseases covered are cancer, genetic disorders, infectious diseases, and others with various workflows such as upstream processing and downstream processing. The various applications used are Gene And Cell Therapy Development, vaccine development, biopharmaceutical and pharmaceutical discovery, and biomedical research used in research organizations, biotech and pharmaceutical companies, and others.

Viral Vector Manufacturing Market Segmentation

The viral vector manufacturing market covered in this report is segmented –

1) By Type: Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types

2) By Disease: Cancer, Genetic Disorders, Infectious Diseases, Other Diseases

3) By Workflow: Upstream Processing, Downstream Processing

4) By Application: Gene And Cell Therapy Development, Vaccine Development, Biopharmaceutical And Pharmaceutical Discovery, Biomedical Research

5) By End-User: Research Organizations, Biotech And Pharmaceutical Companies, Others End Users

Subsegments:

1) By Adenoviral Vectors: Serotype 5, Serotype 2, Serotype 26

2) By Adeno-Associated Viral Vectors: AAV2, AAV5, AAV8, AAV9, Others

3) By Lentiviral Vectors: HIV-1-Based Lentiviral Vectors, SIV-Based Lentiviral Vectors, Others

4) By Retroviral Vectors: Moloney Murine Leukemia Virus (MoMLV), Gammaretroviral Vectors, Others

5) By Other Types: Sendai Viral Vectors, Vesicular Stomatitis Virus (VSV)-Based Vectors, Measles Virus Vectors, Others

Viral Vector Manufacturing Market Size and growth rate 2025 to 2029: Graph

Viral Vector Manufacturing Market Size 2025 And Growth Rate

The viral vector manufacturing market size has grown exponentially in recent years. It will grow from $6.93 billion in 2024 to $8.33 billion in 2025 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to growth in the pipeline of gene therapies, clinical success and approvals, increased investment in biopharmaceuticals, and increased prevalence of genetic disorders

Viral Vector Manufacturing Market Growth Forecast

The viral vector manufacturing market size is expected to see exponential growth in the next few years. It will grow to $17.68 billion in 2029 at a compound annual growth rate (CAGR) of 20.7%. The growth in the forecast period can be attributed to expanding applications in oncology, global collaborations in gene therapy research, adoption of viral vectors in vaccine development, continued clinical trials and commercialization. Major trends in the forecast period include technological innovations in vector production, emergence of next-generation vectors, regulatory compliance and standardization, collaborations and partnerships, and global expansion of manufacturing facilities.

Book your 30 minutes free consultation with our research experts

Contact Us

Viral Vector Manufacturing Market Driver: Impact Of Rising Cancer And Infectious Diseases On The Viral Vector Manufacturing Market

The increase in the prevalence of cancer and infectious diseases is expected to propel the growth of the viral vector manufacturing market going forward. An infectious disease refers to a condition brought on by a virus or its toxic byproduct and spread to a susceptible host via contact with an infected person, animal, or item. Cancer refers to a broad range of illnesses that can develop in any organ or tissue of the body when aberrant cells grow out of control, cross their usual boundaries to invade neighboring organs, and spread to other organs. Tumor antigens, or proteins on tumor cells, are produced via viral vectors to elicit the body's anticancer immune response. In pre-clinical and clinical trials, viral vectors have served as vaccines against various infectious illnesses. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in Australia the number of cancer cases diagnosed increased from 160,570 in 2022 to 164,694 in 2023, reflecting a notable rise over the year. This upward trend highlights the growing prevalence of cancer within the country. Furthermore, For instance, in August 2024, according to the data published by the UK Health Security Agency, a UK-based executive agency, in England, the UK Health Security Agency (UKHSA) reported 368 measles cases in 2023, marking a nearly sevenfold increase from the 53 cases reported in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Therefore, the increase in the prevalence of cancer and infectious diseases is driving the growth of the viral vector manufacturing market.

Viral Vector Manufacturing Market Driver: Gene Therapy Advancements Driving Growth In Viral Vector Manufacturing

The expanding pipeline of gene therapy is expected to propel the growth of the viral vector manufacturing market going forward. Gene therapy is a medical approach that involves introducing, altering, or replacing genetic material within an individual's cells to treat or prevent disease. Viral vector manufacturing aids in expanding the pipeline of gene therapy by providing efficient and scalable platforms for the production of viral vectors, which are essential delivery vehicles for introducing therapeutic genes into target cells, thereby advancing the development of innovative gene therapies. For instance, in January 2023, according to the report of the American Society of Gene & Cell Therapy, a US-based non-profit organization dedicated to the development, understanding, and application of gene, cell, and nucleic acid therapies, there was a 7% growth in the US gene, cell, and RNA therapy pipeline in 2022, reaching a total of 3,726 therapies. The preclinical stage dominates with 70% of therapies, and oncology leads as the most active therapeutic area, hosting over 1,300 gene and cell therapy candidates. Therefore, the expanding pipeline of gene therapy is driving the growth of the viral vector manufacturing market.

Global Viral Vector Manufacturing Market Major Players

Major companies operating in the viral vector manufacturing market include Sanofi S.A., Thermo Fisher Scientific Inc., Merck Group, FUJIFILM Holdings Corporation, Lonza Group, Catalent Inc., Sartorius AG, Charles River Laboratories International Inc., AGC Biologics, Ultragenyx Pharmaceutical Inc., Novasep Holding SAS, Aldevron LLC, Oxford Biomedica plc, LakePharma Inc., Voyager Therapeutics Inc., Mustang Bio Inc., Regenxbio Inc., VGXI Inc., BioNTech IMFS GmbH, FinVector Oy, Vigene Biosciences Inc., Univercells Technologies, Sirion-Biotech GmbH, Cevec Pharmaceuticals GmbH, Batavia Biosciences BV.

Global Viral Vector Manufacturing Market Trend: Product Innovation In The Viral Vector Manufacturing Market

Product innovation is a key trend gaining popularity in the viral vector manufacturing market. Major companies operating in the viral vector manufacturing market are introducing product innovations to sustain their position in the market. For instance, in August 2022, Merck KGaA, a Germany-based science and technology company, launched the VirusExpress 293 Adeno-Associated Virus (AAV) Production Platform. One of the first Contract development and manufacturing organizations and technology creators to offer an entire viral vector manufacturing package, including AAV, Lentiviral, CDMO, CTO, and process development. With the help of this innovative platform, biopharmaceutical businesses may shorten the time and expense of process development while accelerating the time to clinical manufacture

Global Viral Vector Manufacturing Market Trend: Advanced Analytical Viral Vector Platform Propel Market Growth

Major companies operating in the viral vector manufacturing market are focusing on developing advanced products, such as viral vector platforms specifically designed for viral vector production and manufacturing. Viral vector platforms are comprehensive systems tailored to efficiently produce and process viral vectors for applications such as gene therapy and vaccine development. For instance, in May 2023, AGC Biologics, a US-based global biopharmaceutical contract development and manufacturing organization (CDMO), launched the BravoAAV and ProntoLVV platforms, designed to offer flexible and accelerated vector development and manufacturing for cell and gene therapy programs. These platforms, designed for flexible and accelerated vector development and manufacturing in cell and gene therapy programs, offer GMP product delivery in nine months, supported by a global regulatory and supply network and in-house plasmid DNA services. With custom processes, templated material approaches, and prequalified analytical methods, these platforms are significant contributors to the viral vector manufacturing market's projected growth, reaching $5.5 billion by 2035, by meeting the increasing demand for efficient development and delivery of life-changing gene therapies and vaccines.

Viral Vector Manufacturing Market Merger And Acquisition: Oxford Biomedica Strengthens Production Capacity Through Abl Europe Acquisition

In January 2024, Oxford Biomedica Plc, a UK-based biotechnology company, acquired ABL Europe from Institut Mérieux, for $16 million (15 million euros). Through this acquisition, Oxford Biomedica will the production facilities in Lyon and Strasbourg, France, and will be able to offer multi-viral vector CDMO capabilities, boasting six manufacturing sites in the EU, U.S., and U.K. ABL Europe is a France-based contract development and manufacturing organization (CDMO) that provides viral vector manufacturing services.

Regional Outlook For The Global Viral Vector Manufacturing Market

North America was the largest region in the viral vector manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the viral vector manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Viral Vector Manufacturing Market?

The viral vector manufacturing market includes revenues earned by entities through the production, packaging, and labeling of viral vector vaccines. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Viral Vector Manufacturing Industry?

The viral vector manufacturing market research report is one of a series of new reports from The Business Research Company that provides viral vector manufacturing market statistics, including viral vector manufacturing industry global market size, regional shares, competitors with a viral vector manufacturing market share, detailed viral vector manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the viral vector manufacturing industry. This viral vector manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Viral Vector Manufacturing Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $8.33 billion
Revenue Forecast In 2034 $17.68 billion
Growth Rate CAGR of 20.7% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types
2) By Disease: Cancer, Genetic Disorders, Infectious Diseases, Other Diseases
3) By Workflow: Upstream Processing, Downstream Processing
4) By Application: Gene And Cell Therapy Development, Vaccine Development, Biopharmaceutical And Pharmaceutical Discovery, Biomedical Research
5) By End-User: Research Organizations, Biotech And Pharmaceutical Companies, Others End Users Subsegments: 1) By Adenoviral Vectors: Serotype 5, Serotype 2, Serotype 26
2) By Adeno-Associated Viral Vectors: AAV2, AAV5, AAV8, AAV9, Others
3) By Lentiviral Vectors: HIV-1-Based Lentiviral Vectors, SIV-Based Lentiviral Vectors, Others
4) By Retroviral Vectors: Moloney Murine Leukemia Virus (MoMLV), Gammaretroviral Vectors, Others
5) By Other Types: Sendai Viral Vectors, Vesicular Stomatitis Virus (VSV)-Based Vectors, Measles Virus Vectors, Others
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Sanofi S.A., Thermo Fisher Scientific Inc., Merck Group, FUJIFILM Holdings Corporation, Lonza Group, Catalent Inc., Sartorius AG, Charles River Laboratories International Inc., AGC Biologics, Ultragenyx Pharmaceutical Inc., Novasep Holding SAS, Aldevron LLC, Oxford Biomedica plc, LakePharma Inc., Voyager Therapeutics Inc., Mustang Bio Inc., Regenxbio Inc., VGXI Inc., BioNTech IMFS GmbH, FinVector Oy, Vigene Biosciences Inc., Univercells Technologies, Sirion-Biotech GmbH, Cevec Pharmaceuticals GmbH, Batavia Biosciences BV.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Viral Vector Manufacturing Market Characteristics

    3. Viral Vector Manufacturing Market Trends And Strategies

    4. Viral Vector Manufacturing Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

    5. Global Viral Vector Manufacturing Growth Analysis And Strategic Analysis Framework

    5.1. Global Viral Vector Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Viral Vector Manufacturing Market Growth Rate Analysis

    5.4. Global Viral Vector Manufacturing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Viral Vector Manufacturing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Viral Vector Manufacturing Total Addressable Market (TAM)

    6. Viral Vector Manufacturing Market Segmentation

    6.1. Global Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Adenoviral Vectors

    Adeno-Associated Viral Vectors

    Lentiviral Vectors

    Retroviral Vectors

    Other Types

    6.2. Global Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cancer

    Genetic Disorders

    Infectious Diseases

    Other Diseases

    6.3. Global Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Upstream Processing

    Downstream Processing

    6.4. Global Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Gene And Cell Therapy Development

    Vaccine Development

    Biopharmaceutical And Pharmaceutical Discovery

    Biomedical Research

    6.5. Global Viral Vector Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Research Organizations

    Biotech And Pharmaceutical Companies

    Others End Users

    6.6. Global Viral Vector Manufacturing Market, Sub-Segmentation Of Adenoviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Serotype 5

    Serotype 2

    Serotype 26

    6.7. Global Viral Vector Manufacturing Market, Sub-Segmentation Of Adeno-Associated Viral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    AAV2

    AAV5

    AAV8

    AAV9

    6.8. Global Viral Vector Manufacturing Market, Sub-Segmentation Of Lentiviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    HIV-1-Based Lentiviral Vectors

    SIV-Based Lentiviral Vectors

    Others

    6.9. Global Viral Vector Manufacturing Market, Sub-Segmentation Of Retroviral Vectorss, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Moloney Murine Leukemia Virus (MoMLV)

    Gammaretroviral Vectors

    Others

    6.10. Global Viral Vector Manufacturing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Sendai Viral Vectors

    Vesicular Stomatitis Virus (VSV)-Based Vectors

    Measles Virus Vectors

    Others

    7. Viral Vector Manufacturing Market Regional And Country Analysis

    7.1. Global Viral Vector Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Viral Vector Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Viral Vector Manufacturing Market

    8.1. Asia-Pacific Viral Vector Manufacturing Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Viral Vector Manufacturing Market

    9.1. China Viral Vector Manufacturing Market Overview

    9.2. China Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Viral Vector Manufacturing Market

    10.1. India Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Viral Vector Manufacturing Market

    11.1. Japan Viral Vector Manufacturing Market Overview

    11.2. Japan Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Viral Vector Manufacturing Market

    12.1. Australia Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Viral Vector Manufacturing Market

    13.1. Indonesia Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Viral Vector Manufacturing Market

    14.1. South Korea Viral Vector Manufacturing Market Overview

    14.2. South Korea Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Viral Vector Manufacturing Market

    15.1. Western Europe Viral Vector Manufacturing Market Overview

    15.2. Western Europe Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Viral Vector Manufacturing Market

    16.1. UK Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Viral Vector Manufacturing Market

    17.1. Germany Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Viral Vector Manufacturing Market

    18.1. France Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Viral Vector Manufacturing Market

    19.1. Italy Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Viral Vector Manufacturing Market

    20.1. Spain Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Viral Vector Manufacturing Market

    21.1. Eastern Europe Viral Vector Manufacturing Market Overview

    21.2. Eastern Europe Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Viral Vector Manufacturing Market

    22.1. Russia Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Viral Vector Manufacturing Market

    23.1. North America Viral Vector Manufacturing Market Overview

    23.2. North America Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Viral Vector Manufacturing Market

    24.1. USA Viral Vector Manufacturing Market Overview

    24.2. USA Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Viral Vector Manufacturing Market

    25.1. Canada Viral Vector Manufacturing Market Overview

    25.2. Canada Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Viral Vector Manufacturing Market

    26.1. South America Viral Vector Manufacturing Market Overview

    26.2. South America Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Viral Vector Manufacturing Market

    27.1. Brazil Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Viral Vector Manufacturing Market

    28.1. Middle East Viral Vector Manufacturing Market Overview

    28.2. Middle East Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Viral Vector Manufacturing Market

    29.1. Africa Viral Vector Manufacturing Market Overview

    29.2. Africa Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Viral Vector Manufacturing Market Competitive Landscape And Company Profiles

    30.1. Viral Vector Manufacturing Market Competitive Landscape

    30.2. Viral Vector Manufacturing Market Company Profiles

    30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Merck Group Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. FUJIFILM Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Lonza Group Overview, Products and Services, Strategy and Financial Analysis

    31. Viral Vector Manufacturing Market Other Major And Innovative Companies

    31.1. Catalent Inc.

    31.2. Sartorius AG

    31.3. Charles River Laboratories International Inc.

    31.4. AGC Biologics

    31.5. Ultragenyx Pharmaceutical Inc.

    31.6. Novasep Holding SAS

    31.7. Aldevron LLC

    31.8. Oxford Biomedica plc

    31.9. LakePharma Inc.

    31.10. Voyager Therapeutics Inc.

    31.11. Mustang Bio Inc.

    31.12. Regenxbio Inc.

    31.13. VGXI Inc.

    31.14. BioNTech IMFS GmbH

    31.15. FinVector Oy

    32. Global Viral Vector Manufacturing Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Viral Vector Manufacturing Market

    34. Recent Developments In The Viral Vector Manufacturing Market

    35. Viral Vector Manufacturing Market High Potential Countries, Segments and Strategies

    35.1 Viral Vector Manufacturing Market In 2029 - Countries Offering Most New Opportunities

    35.2 Viral Vector Manufacturing Market In 2029 - Segments Offering Most New Opportunities

    35.3 Viral Vector Manufacturing Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Viral Vector Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Viral Vector Manufacturing Market, Sub-Segmentation Of Adenoviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Viral Vector Manufacturing Market, Sub-Segmentation Of Adeno-Associated Viral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Viral Vector Manufacturing Market, Sub-Segmentation Of Lentiviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Viral Vector Manufacturing Market, Sub-Segmentation Of Retroviral Vectorss, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Viral Vector Manufacturing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Viral Vector Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Viral Vector Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Sanofi S.A. Financial Performance
  • Table 82: Thermo Fisher Scientific Inc. Financial Performance
  • Table 83: Merck Group Financial Performance
  • Table 84: FUJIFILM Holdings Corporation Financial Performance
  • Table 85: Lonza Group Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Viral Vector Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Viral Vector Manufacturing Market, Sub-Segmentation Of Adenoviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Viral Vector Manufacturing Market, Sub-Segmentation Of Adeno-Associated Viral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Viral Vector Manufacturing Market, Sub-Segmentation Of Lentiviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Viral Vector Manufacturing Market, Sub-Segmentation Of Retroviral Vectorss, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Viral Vector Manufacturing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Viral Vector Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Viral Vector Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Viral Vector Manufacturing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Viral Vector Manufacturing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Sanofi S.A. Financial Performance
  • Figure 82: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 83: Merck Group Financial Performance
  • Figure 84: FUJIFILM Holdings Corporation Financial Performance
  • Figure 85: Lonza Group Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Read More

What Is The Compression Therapy Market Overview In 2022?

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the high potency apis market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the protein purification and isolation market research report 2022 with industry size, share, segments and market growth

Read More

Viral Vectors And Plasmid DNA Global Market Report 2025 – By Product (Plasmid DNA, Viral Vectors), By Disease (Infectious Diseases, Genetic Disorders, Cancer, Other Diseases), By Application (Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Other Applications), By End User (Research Institutes, Biopharmaceutical And Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Vector Control Global Market Report 2025 – By Method of Control (Chemical, Physical and Mechanical, Biological, Other Method Of Control), By Vector Type (Insects, Rodents, Other Vector Types), By Application (Residential, Commercial, Industrial) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Bacterial And Plasmid Vectors Global Market Report 2025 – By Host Type (E.Coli Expression Vectors, Other Bacterial Expression Vectors), By Application (Genetics, Molecular Biology, Bioinformatics, Other Applications), By End Users (Hospitals, Homecare, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Thrust Vector Control Global Market Report 2025 – By Type (Gimbal Nozzle, Thrusters, Flex Nozzle, Rotating Nozzle, Other Types), By System (Thrust Vector Actuation System, Thrust Vector Injection System, Thrust Vector Thruster System), By Application (Launch Vehicles, Satellites, Missiles, Fighter Aircraft), By End-User (Space Agencies, Defense ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Protein Expression Global Market Report 2025 – By Protein Expression (Yeast Expression, Mammalian Expression, Algae Expression, Insect Expression, Bacterial Expression, Cell-free Expression), By Product (Reagents, Competent Cells, Expression vectors, Services, Instruments), By Application (Therapeutic, Industrial, Research), By End Use (Pharmaceutical And Biotechnological Companies, Academic Research, Contract Research Organizations) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Gene Therapy Global Market Report 2025 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders), By End Users (Biopharmaceutical Companies, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

CRISPR Technology Global Market Report 2025 – By Product Type (Design Tools, Plasmid And Vector, Cas9 And G-RNA, Delivery System Products), By Application (Biomedical, Agriculture, Diagnostics, Other Applications), By End-User (Academic Research Organizations, Biopharmaceutical Companies, Agricultural Biotechnology Companies, Contract Research Organizations (CROs)) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Recombinant DNA Technology Global Market Report 2025 – By Product Type( Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, Gene Editing ), By Component Type( Expression System, Cloning Vector), By Application Type( Food And Agriculture, Health And Disease, Environment, Other Application Types), By End-Use Type( Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Viral Vector Manufacturing market?

Viral vector manufacturing refers to producing viral vectors, tools that deliver genetic material into cells. A viral vector is a tool for gene transfer that can manipulate a particular cell type or tissue to express therapeutic genes. For further insights on the Viral Vector Manufacturing market, request a sample here

How will the Viral Vector Manufacturing market drivers and restraints affect the market dynamics? What forces will shape the Viral Vector Manufacturing industry going forward?

The Viral Vector Manufacturing market major growth driver - Impact Of Rising Cancer And Infectious Diseases On The Viral Vector Manufacturing Market. For further insights on the Viral Vector Manufacturing market, request a sample here

What is the forecast market size or the forecast market value of the Viral Vector Manufacturing market?

The Viral Vector Manufacturing market size has grown strongly in recent years. The viral vector manufacturing market size has grown exponentially in recent years. It will grow from $6.93 billion in 2024 to $8.33 billion in 2025 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to growth in the pipeline of gene therapies, clinical success and approvals, increased investment in biopharmaceuticals, and increased prevalence of genetic disorders The viral vector manufacturing market size is expected to see exponential growth in the next few years. It will grow to $17.68 billion in 2029 at a compound annual growth rate (CAGR) of 20.7%. The growth in the forecast period can be attributed to expanding applications in oncology, global collaborations in gene therapy research, adoption of viral vectors in vaccine development, continued clinical trials and commercialization. Major trends in the forecast period include technological innovations in vector production, emergence of next-generation vectors, regulatory compliance and standardization, collaborations and partnerships, and global expansion of manufacturing facilities. For further insights on the Viral Vector Manufacturing market, request a sample here

How is the Viral Vector Manufacturing market segmented?

The viral vector manufacturing market covered in this report is segmented –
1) By Type: Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types
2) By Disease: Cancer, Genetic Disorders, Infectious Diseases, Other Diseases
3) By Workflow: Upstream Processing, Downstream Processing
4) By Application: Gene And Cell Therapy Development, Vaccine Development, Biopharmaceutical And Pharmaceutical Discovery, Biomedical Research
5) By End-User: Research Organizations, Biotech And Pharmaceutical Companies, Others End Users Subsegments:
1) By Adenoviral Vectors: Serotype 5, Serotype 2, Serotype 26
2) By Adeno-Associated Viral Vectors: AAV2, AAV5, AAV8, AAV9, Others
3) By Lentiviral Vectors: HIV-1-Based Lentiviral Vectors, SIV-Based Lentiviral Vectors, Others
4) By Retroviral Vectors: Moloney Murine Leukemia Virus (MoMLV), Gammaretroviral Vectors, Others
5) By Other Types: Sendai Viral Vectors, Vesicular Stomatitis Virus (VSV)-Based Vectors, Measles Virus Vectors, Others For further insights on the Viral Vector Manufacturing market, request a sample here

Which region has the largest share of the Viral Vector Manufacturing market? What are the other regions covered in the report?

North America was the largest region in the viral vector manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Viral Vector Manufacturing market, request a sample here.

Who are the major players in the Viral Vector Manufacturing market?

Major companies operating in the viral vector manufacturing market include Sanofi S.A., Thermo Fisher Scientific Inc., Merck Group, FUJIFILM Holdings Corporation, Lonza Group, Catalent Inc., Sartorius AG, Charles River Laboratories International Inc., AGC Biologics, Ultragenyx Pharmaceutical Inc., Novasep Holding SAS, Aldevron LLC, Oxford Biomedica plc, LakePharma Inc., Voyager Therapeutics Inc., Mustang Bio Inc., Regenxbio Inc., VGXI Inc., BioNTech IMFS GmbH, FinVector Oy, Vigene Biosciences Inc., Univercells Technologies, Sirion-Biotech GmbH, Cevec Pharmaceuticals GmbH, Batavia Biosciences BV. . For further insights on the Viral Vector Manufacturing market, request a sample here.

What are the key trends in the Viral Vector Manufacturing market?

Major trends in the Viral Vector Manufacturing market include Product Innovation In The Viral Vector Manufacturing Market. For further insights on the Viral Vector Manufacturing market, request a sample here.

What are the major opportunities in the Viral Vector Manufacturing market? What are the strategies for the Viral Vector Manufacturing market?

For detailed insights on the major opportunities and strategies in the Viral Vector Manufacturing market, request a sample here.

How does the Viral Vector Manufacturing market relate to the overall economy and other similar markets?

For detailed insights on Viral Vector Manufacturing's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Viral Vector Manufacturing industry?

For detailed insights on the mergers and acquisitions in the Viral Vector Manufacturing industry, request a sample here.

What are the key dynamics influencing the Viral Vector Manufacturing market growth? SWOT analysis of the Viral Vector Manufacturing market.

For detailed insights on the key dynamics influencing the Viral Vector Manufacturing market growth and SWOT analysis of the Viral Vector Manufacturing industry, request a sample here.